1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.
Lupin Ltd. Ask MarketMind AI v1.5
NSE: LUPIN | BSE: 500257

Lupin Live Share Price Today, Share Analysis and Chart

Iran war impact

Based on the latest financial disclosures and management commentary as of March 20, 2026, the impact of the Middle East conflict on Lupin Ltd. is primarily minimal to slightly negative. While the company has a global footprint, its direct exp...

Read More
2333.80 38.70 (1.69%)
1.3M
NSE+BSE Volume

NSE 10 Apr, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Approval
Lupin gets US FDA nod for ANDA for Dapagliflozin tablets, with a market size of $10.5 bn in 2025 See details
Loading... You have run out of DVM views!
Subscribe now to see details
High Financial Strength
- / 100
Mid Valuation
- / 100
Technically Moderately Bullish
60.5 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

Lupin Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
936 Votes:
Buy 72.86%
Sell 17.52%
Hold 9.62%
BUY
SELL
HOLD
Ask AI